PCMdb: Pancreatic cancer methylation database

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Nagpal, Gandharva ^a   Sharma, Minakshi ^a   Kumar, Shailesh ^a   Chaudhary, Kumardeep ^a   Gupta, Sudheer ^a   Gautam, Ankur ^a   Raghava, Gajendra P S ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR PROTEIN;

ARTICLE; DNA METHYLATION; GENETIC MARKER; GENETICS; HUMAN; MALE; PANCREAS TUMOR; PROTEIN DATABASE;

DATABASES, PROTEIN; DNA METHYLATION; DNA, NEOPLASM; GENETIC MARKERS; HUMANS; MALE; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS;

EID: 84898638952     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04197     Document Type: Article

References (22)

1. Siegel, R.,Naishadham,D.&Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10-29 (2012).
2. Costello, E., Greenhalf, W. & Neoptolemos, J. P. New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol 9, 435-444 (2012).
3. Harsha, H. C. et al. A compendium of potential biomarkers of pancreatic cancer. PLoS Med 6, e1000046 (2009).
4. Bauer, A. S. et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 7, e34151 (2012).
5. Yachida, S. & Iacobuzio-Donahue, C. A. Evolution and dynamics of pancreatic cancer progression. Oncogene 32, 5253-5260 (2013).
6. Iacobuzio-Donahue, C. A., Velculescu, V. E., Wolfgang, C. L. & Hruban, R. H. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res 18, 4257-4265 (2012).
7. Baylin, S. B.&Jones, P. A. Adecade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 11, 726-734 (2011).
8. Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428 (2002).
9. Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683-692 (2007).
10. Esteller, M. et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343, 1350-1354 (2000).
11. Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352, 997-1003 (2005).
12. Tan, A. C. et al. Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol 3, 425-438 (2009).
13. Ramachandran, K., Miller, H., Gordian, E., Rocha-Lima, C. & Singal, R. Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity. Anticancer Res 30, 3919-3925 (2010).
14. He, X. et al. MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res 36, D836-841 (2008).
15. Baek, S. J. et al.MENT: methylation and expression database of normal and tumor tissues. Gene 518, 194-200 (2013).
16. Lv, J. et al. DiseaseMeth: a human disease methylation database. Nucleic Acids Res 40, D1030-1035 (2012).
17. House, M. G., Guo, M., Iacobuzio-Donahue, C. & Herman, J. G. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 24, 193-198 (2003).
18. Hong, S. M. et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 21, 1499-1507 (2008).
19. Kumar, R. et al. CancerDR: Cancer Drug Resistance Database. Sci. Rep. 3, 1445; DOI:10.1038/srep01445 (2013).
20. Heyn, H. & Esteller, M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 13, 679-692 (2012).
21. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J Mol Biol 215, 403-410 (1990).
22. Pearson, W. R. Flexible sequence similarity searching with the FASTA3 program package. Methods Mol Biol 132, 185-219 (2000).